Understanding Treatment Provider Disputes in NSW CTP Claims
When a motor accident occurs in New South Wales, the Compulsory Third Party (CTP) insurance scheme provides coverage for treatment and care. Disputes may arise when an insurer refuses to approve a treatment provider, limits the number of treatment sessions, or caps the cost of services. These disputes are common in Greater Sydney, where access to specialist care and high medical costs can create tension between claimants and insurers. The Motor Accident Injuries Act 2017 (MAIA) and the Motor Accident Injuries Regulation 2017 set the legal framework for treatment approval and funding. Insurers must follow the Motor Accident Guidelines, which define what treatments are reasonable and necessary. A claimant may not be able to access a preferred provider if the insurer deems the treatment not aligned with the guidelines, or if the provider lacks formal approval under the CTP scheme.
Common Causes of Treatment Provider Disputes
Disputes often stem from differences in clinical opinion, insurer policy interpretation, or administrative delays. A common example in Greater Sydney involves a claimant who sustained a whiplash injury in a rear-end collision on the M4 Motorway near Lidcombe. The claimant’s general practitioner referred them to a private physiotherapist in Newtown, but the insurer declined approval, stating the treatment was not supported by the Motor Accident Guidelines. Another example occurred in the Sydney CBD, where a cyclist injured in a collision with a delivery van sought treatment from a registered osteopath in North Sydney. The insurer approved only ten sessions, despite the treating practitioner recommending 20 for recovery. These cases reflect broader issues: insurers may apply strict interpretations of the guidelines, or delay approval pending review, which can delay recovery.
How SIRA Guidelines Apply to Dispute Resolution
The State Insurance Regulatory Authority (SIRA) oversees CTP claims and provides guidance on treatment approval. Under the MAIA, treatment must be reasonable and necessary for recovery from injuries sustained in a motor accident. SIRA’s Motor Accident Guidelines specify that treatment must be evidence-based and aligned with best practice. Insurers must act in good faith and cannot unreasonably refuse treatment. If a claimant believes the insurer’s decision is unreasonable, they may request a review under the insurer’s internal dispute resolution process. SIRA does not directly intervene in treatment approval decisions, but it provides a framework for review and supports claimants through the dispute process.
Practical Steps to Resolve a Dispute
If a dispute arises, claimants should act promptly. First, obtain a written decision from the insurer outlining the reasons for refusal or limitation. Next, request a review from the insurer’s internal dispute resolution team. This process must begin within 28 days of receiving the decision. If the review is unsuccessful, the claimant may escalate to the Personal Injury Commission (PIC), which handles medical disputes under the MAIA. The PIC can review whether the treatment was reasonable and necessary, and whether the insurer’s decision was fair. Claimants must provide medical evidence, including a treatment plan from a qualified practitioner, records of prior treatment, and any correspondence with the insurer. Photographs of the accident scene, witness statements, and a detailed diary of symptoms and treatment progress can also support the claim.
Time Limits and Dispute Pathways
There are strict time limits for challenging a treatment decision. A claimant must notify the insurer of a dispute within 28 days of receiving the decision. Failure to do so may result in the dispute being closed. The internal review process must be completed within 30 days. If the claimant disagrees with the outcome, they may apply to the Personal Injury Commission within 60 days of the review decision. The PIC will assess the medical evidence and may order the insurer to approve the treatment or increase the approved sessions. A claimant must not delay treatment while disputing approval, as this may affect the recovery timeline and future entitlements.
Hypothetical Example: A Case from Eastern Suburbs
A 38-year-old woman was struck by a car while crossing a pedestrian crossing in Bondi Junction. She sustained a soft tissue injury to her neck and back. Her treating physiotherapist in Coogee recommended 16 sessions over eight weeks. The insurer approved only six sessions, citing the Motor Accident Guidelines’ emphasis on conservative treatment for soft tissue injuries. The claimant submitted a detailed treatment plan, including MRI results showing ligament strain, and a letter from her GP confirming ongoing pain and limited mobility. After an internal review was denied, she applied to the Personal Injury Commission. The PIC reviewed the medical evidence and found the treatment was reasonable and necessary. The insurer was ordered to approve the full course of treatment. This example shows that medical evidence and timely escalation are critical to resolving disputes.
When to Seek Independent Advice
A dispute over treatment approval does not mean the claimant will succeed. Insurers may still maintain their position, and the PIC’s decision is not binding on the insurer unless the claimant proceeds to a formal hearing. However, seeking advice from a qualified medical practitioner or legal professional can clarify whether the treatment is appropriate and whether the insurer’s decision was reasonable. Claimants should not alter or fabricate medical records. Instead, they should preserve all documentation and keep a record of all communications with the insurer. The process is not guaranteed to result in approval, but it provides a structured pathway to challenge a decision.
Every claim depends on its own facts. To request contact about your circumstances, complete the quick, no obligation enquiry form.